Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transductio...
Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction
About this item
Full title
Author / Creator
Liu, Bin , Xu, Tonghong , Xu, Xinning , Cui, Yuzhu and Xing, Xiaojing
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Biglycan (BGN) is overexpressed in cancer stem cells of colon cancer and induces the activation of NF-κB pathway which contributes to the chemotherapy resistance of diverse cancer types. Therefore, we hypothesized that the overexpression of BGN also promoted the development of multiple drug resistance (MDR) in colon cancer via NF-κB pathway. The ex...
Alternative Titles
Full title
Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2039294617
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2039294617
Other Identifiers
ISSN
0300-8177
E-ISSN
1573-4919
DOI
10.1007/s11010-018-3365-1
